For UK HealthTech companies
You have a great HealthTech product, but no structured UK go-to-market plan
UK HealthTech GTM requires a route that accounts for NHS procurement complexity, ICB geography, clinical champion development, and commercial model design. Most companies build a product plan and assume the commercial plan follows. It doesn't.
Cost of Inaction
Enter your target accounts, live deployments today, average contract value, and achievable conversion rate. The calculator shows the annual revenue gap above today's contracts.
How it breaks down
- Current contracted revenue£270,000
- Revenue at target penetration£324,000
Two minutes, no typing, and I read every one myself.
From Paul
Tell me where that £54,000 is coming from, and I'll come back with the three things to fix first.
A few quick questions, about two minutes, and no typing. I read every one myself and reply with the three things costing you most and where I'd start. If it's useful, we talk. If not, you've still got a clear picture.
No obligation, no sales call unless you ask for one, and nothing automated lands in your inbox.
Paul, Solvable
Frequently asked questions
Why does this problem persist?
A strong product is not matched by a structured market plan The NHS route to market is complex and not yet mapped Activity is opportunistic rather than aimed at a target segment
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.